Reciprocal products of chromosomal translocations in human cancer pathogenesis: Key players or innocent bystanders?

Trends in Molecular Medicine

Volumn 8, Issue 8, 2002, Pages 396-405

  Rego, Eduardo M ^a   Pandolfi, Pier Paolo ^a,b  

^a Department of Molecular Biology and Genetics   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; GUANOSINE TRIPHOSPHATASE; HYBRID PROTEIN; RETINOIC ACID RECEPTOR ALPHA; STAT PROTEIN;

CHROMOSOME 17; CHROMOSOME TRANSLOCATION; FUSION GENE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENETIC ASSOCIATION; LYMPHOMA; MOUSE; NONHUMAN; PATHOGENESIS; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; SARCOMA; X CHROMOSOME;

ANIMALS; CHROMOSOMES, HUMAN; GTP PHOSPHOHYDROLASES; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; ONCOGENE PROTEINS, FUSION; ONCOGENES; RECEPTORS, RETINOIC ACID; TRANSLOCATION, GENETIC;

EID: 0036319425     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02384-5     Document Type: Review

References (89)

1. Chromosomal translocations in human cancer
2. The role of chromosome translocations in leukemogenesis
3. Mechanisms of chromosomal translocations in B-cell lymphomas
4. Cloning and sequencing of a c-myc oncogene, in a Burkitt's lymphoma cell line that is translocated to a germ line α switch region
5. A translocated human c-myc oncogene is altered in a conserved coding sequence
6. The c-myc oncogene perturbs B lymphocyte development in E-mumyc transgenic mice
7. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
8. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
9. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma
10. Unique fusion of bcr and c-ab1 genes in Philadelphia chromosome positive acute lymphoblastic leukemia
11. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia
12. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
13. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia
14. Expression pattern of the RARα/PML fusion gene in acute promyelocytic leukemia
15. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party
16. Heterogeneity in CBF β/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia
17. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs
18. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia
19. The der(11) chromosome contains the critical breakpoint junction in the 4;11, 9;11, and 11;19 translocations in acute leukemia
20. Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia
21. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia
22. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family
23. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6; 9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia
24. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation
25. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
26. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
27. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations
28. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia
29. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15)
30. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein
31. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia
32. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)
33. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
34. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
35. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia
36. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor
37. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia
38. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
39. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
40. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia
41. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23)
42. A novel gene, AF-1p, fused to HRX in t(1;11) (p32;q23), is not related to AF-4,AF-9 nor ENL
43. Alterations at the rel locus in human lymphoma
44. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
45. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma
46. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4; 16)(q26;p13) translocation in a malignant T cell lymphoma
47. Combinatorial generation of variable fusion proteins in the Ewing family of tumours
48. A second Ewing's sarcoma translocation, t(21,22), fuses the EWS gene to another ETS-family transcription factor, ERG
49. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1
50. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
51. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma
52. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumour
53. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
54. A t(10; 17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma
55. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma
56. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
57. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive entity previously included among renal cell carcinomas of children and adolescents
58. Translocation t(12; 16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis
59. Proposal for the classification of the acute leukemias
60. Molecular pathogenesis of acute promyelocytic leukemia
61. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
62. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences
63. Acute leukemia with promyelocytic features in PML/RARα transgenic mice
64. A PMLRARα transgene initiates murine acute promyelocytic leukemia
65. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL
66. A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia
67. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
68. The function of PML in p53-dependent apoptosis
69. Role of promyelocytic leukemia (PML) protein in tumour suppression
70. Translocations of the RARα gene in acute promyelocytic leukemia
71. Two critical hits for promyelocytic leukemia
72. Plzf regulates limb and axial skeletal patterning
73. RAR α1/RAR α2-PML mRNA expression in acute promyelocytic leukemic cells: A molecular and laboratory-clinical correlative study
74. Diagnosis of acute promyelocytic leukaemia by RT-PCR: Detection of PML-RARA and RARA-PML fusion transcripts
75. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes
76. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice
77. A recurring nonrandom pattern of chromosomal aberrations is associated with the development of acute promyelocytic leukemia in PLZF-RARα/ RARα-PLZF transgenic mice
78. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
79. Tyresine kinase activity and transformation potency of BCR-ABL oncogene products
80. Chronic myeloid leukemia from basics to bedside
81. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia
82. Lack of correlation between ABL-BCR expression and response to interferon-α in chronic myeloid leukaemia
83. ABL-BCR expression does not correlate with delations on the derivative chromosome 9 or survival in chronic myeloid leukemia
84. ABL-BCR expression in BCR-ABL-positive human leukemia cell lines
85. Bcr encodes a GTPase-activating protein for p21rac
86. Alveolar soft part sarcoma: Clinical course and patterns of metastasis in 70 patients treated at a single institution
87. Alveolar soft-part sarcoma. A clinicopathologic study of half a century
88. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor to ASPL, a novel gene at 17q25
89. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma associated TFE3 and PRCC (fusion) proteins